Please ensure Javascript is enabled for purposes of website accessibility

Why Amwell Blasted Higher on Wednesday

By Eric Volkman – Oct 7, 2020 at 6:06PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It helps that the company operates in the white-hot telehealth segment.

What happened

American Well (AMWL 3.96%), also known as Amwell, rose as high as 16% on Wednesday before settling down to a still-impressive 8% gain on the day.

The catalyst seems to be a report the company released on Tuesday indicating sharper-than-expected take-up of telehealth services, Amwell's stock in trade.

So what

The 2020 edition of Amwell's annual Physician and Consumer Survey found that both healthcare practitioners and patients anticipate using telehealth services more frequently after the coronavirus pandemic -- assuming it ever ends -- than they did in the times before the outbreak.

Elderly man using telemedicine services.

Image source: Getty Images.

Twenty-two percent of the consumers Amwell surveyed used telehealth services for a doctor visit or visits this year; that number for healthcare practitioners is 80%. Those numbers are up considerably from the 2019 results of 8% and 22%, respectively.

"This shift suggests the beginning of a rapid transition to a hybrid care model that combines both virtual and physical care settings," Amwell co-CEO Ido Schoenberg said. 

Now what

But is this trend resilient enough to last beyond COVID-19? After all, when the pandemic recedes, we'll be able to go back to standard in-person doctor visits without risking our lives to do so.

Most likely, the trend will endure and even accelerate. Even without a pandemic, modern life is complicated, busy, and stressful. Telehealth services help alleviate all of this, and thanks to technology, they are simple to access and use. Amwell investors are right to be optimistic about these latest findings.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Amwell Stock Quote
$3.54 (3.96%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.